Anti-cancer compounds targeting Ral GTPases and methods of using the same
US9353121B2 · kind B2 · utility
6Cited by
3References
6Claims
0Family size
Inventors
Key dates
| Filing date | Dec 21, 2012 |
| Grant date | May 31, 2016 |
| Priority date | — |
| Expiry date | Dec 21, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of inhibiting the growth or metastasis of a cancer in a mammal by inhibiting a Ral GTPase in the mammal. The invention also provides small molecule inhibitors of Ral GTPases useful in the methods of the invention and pharmaceutical compositions containing the therapeutically effective compounds of the invention, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.